ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 012,38
-0,56%
Dow Jones
38 852,86
-0,55%
DAX
18 610,07
-0,40%
Brent Oil
84,68
0,42%
Bitcoin
67 810,64
-0,70%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enlivex Therapeutics Ltd (ENLV)

  7. Enlivex Therapeutics Ltd (ENLV) Actualités

ENLV Enlivex Therapeutics Ltd

1,38
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:03
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enlivex Therapeutics Ltd ENLV NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,38 10:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,38
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/5/202414:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202414:12GLOBEEnlivex Therapeutics Announces up to $15 Million Registered..
29/4/202414:00GLOBEEnlivex CEO Issues Letter to Shareholders – Perspectives on..
22/4/202414:00GLOBEEnlivex Announces Dosing of First Two Patients in its..
16/4/202422:55APSYet Another Biotech Stock Has Found Success During Tuesday's..
16/4/202413:50GLOBEEnlivex Announces Authorization from the Danish Regulatory..
11/4/202420:58GLOBEEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m...
11/4/202414:05GLOBEEnlivex Announces Topline Results of Its Phase II Trial..
07/2/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202414:00GLOBEEnlivex Announces Issuance of New U.S. Patent Covering..
22/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202414:00GLOBEEnlivex Receives IMOH Regulatory Authorization for the..
20/12/202314:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202322:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
ENLV
Enlivex Therapeutics
BIT
F39278
Vontobel Financial Produ...
BIT
P1INR1
BNP Paribas Issuance
BOV
BBASV490
BBASV490 Ex:23,97
BIT
VEAA
Visibilia Editore
EU
BEB157554408
Euronext VPU Public auct...
LSE
BY05
Citi Fun 24
COIN
PRIAETH
PRIA
COIN
OPENNBTC
OPEN Platform
BINA
FRONTBTC
Frontier Token
BOV
CMCS34M
Comcast DRN MB
LSE
XCX5
Xindia Sw
BIT
F39575
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés